|
Methods for Treating Acute Myeloid Leukemia with Mir-150 Nanoparticles (116-038)
Acute myeloid leukemia (AML) is one of the most common and fatal forms of hematopoietic malignancies. With standard chemotherapies, only 30-40% AML patients under 60 and 5-15% of AML patients older than 60 survive more than 5 years. One avenue for new treatment is through treatment with microRNAs (miRNA); however, successful clinical implementation...
Published: 8/30/2023
|
Updated: 8/30/2023
|
Inventor(s): Zejuan Li, Seungpyo Hong, Xi Jiang, Jianjun Chen
Keywords(s):
Category(s): Technology Classifications > Life Sciences > Diseases & Disorders > Cancer, Technology Classifications > Life Sciences, Technology Classifications > Life Sciences > Diseases & Disorders, Technology Classifications > Life Sciences > Biomedical, Technology Classifications > Life Sciences > Therapeutics
|